Aspirin treatment increases the risk of cerebral microbleeds

Lihong Ge1, Guangming Niu, Xiaodong Han

  • 1Department of Imaging, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China.

Abstract

Insights

Long-term aspirin use in Chinese patients with a history of stroke or TIA significantly increases the risk of cerebral microbleeds (CMBs) and intracerebral hemorrhage (ICH). This highlights the importance of monitoring for these complications in patients on long-term aspirin therapy.

Area of Science:

  • Neurology
  • Radiology
  • Pharmacology

Background:

  • Cerebral microbleeds (CMBs) are small hemorrhages in the brain, often associated with cerebrovascular disease.
  • Aspirin is commonly prescribed for patients with a history of transient ischemic attack (TIA) or stroke to prevent further events.
  • Phase-sensitive imaging offers advanced detection capabilities for CMBs.

Purpose of the Study:

  • To investigate the frequency of cerebral microbleeds (CMBs) in patients with a history of TIA or stroke undergoing aspirin treatment.
  • To compare CMB prevalence between patients on long-term aspirin and controls not receiving aspirin.
  • To identify risk factors associated with CMBs in these patient groups.

Main Methods:

  • Retrospective analysis of 300 outpatients with ischemic cerebrovascular disease.
  • Two groups were studied: 150 patients on aspirin for >1 year and 150 controls without prior aspirin use.
  • Cerebral microbleeds were identified using phase-sensitive magnetic resonance imaging (MRI) and other MRI sequences by a blinded observer. Vascular risk factors were also assessed.

Main Results:

  • The frequency of CMBs was significantly higher in aspirin-treated patients (40%) compared to controls (12%).
  • Intracerebral hemorrhage (ICH) was also significantly more frequent in the aspirin group (28% vs 1%).
  • Long-term aspirin use (>5 years) was associated with a substantially higher CMB frequency (62% vs 22%). White matter hyperintensity, age, and hypertension were also linked to CMBs.

Conclusions:

  • Aspirin treatment, particularly long-term use, significantly increases the occurrence of CMBs and associated intracerebral hemorrhage in Chinese patients with a history of ischemic cerebrovascular events.
  • The findings underscore the impact of aspirin on hemorrhagic complications in this patient population.
  • Phase-sensitive imaging is a valuable tool for detecting CMBs.

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...